DEXAMETHASONE ELIXIR, USP, 0.5 mg/5 mL, 8 fl.oz., Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL, NDC 0603-1147-56
Published February 1, 2017 · Recall initiated: January 16, 2017
Summary
FDA records drug Class III recall D-0438-2017, published February 1, 2017 and initiated January 16, 2017. Recalling firm: Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals; Status: Terminated; Reported quantity: 2568 bottles; Lot: Lot # 0000007104; Exp 05/17. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/ Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals
- Distributor
- Nationwide
- Lot
- Lot # 0000007104; Exp 05/17
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFurosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216,February 1, 2017
- FDAAlbuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, Rx only, Mfd. for WatsonFebruary 1, 2017
- FDAAmoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for:February 1, 2017
- FDAAPD Set with Cassette 3-Prong Peritoneal Dialysis Set Indicated for use in the treatment of patients withJanuary 25, 2017
- FDADigital RID Plate Reader and Software Product Code: AD400January 25, 2017
- FDALisinopril Tablets, USP, 40 mg, a) 45-count bottle (NDC 0603-4214-60), b) 500-count bottle (NDC 0603-4214-28),September 9, 2015
Questions about this recall
Was DEXAMETHASONE ELIXIR, USP, 0.5 mg/5 mL, 8 fl.oz., Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL, NDC 0603-1147-56 recalled?
Yes. FDA published recall D-0438-2017 on February 1, 2017. Reported hazard: Failed Impurities/ Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter